WELCOME

NDC	HCPCS	HCPCS Description	NDC Label	Route of Administration
38779-0071-05	J7638	DEXAMETHASONE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM	DEXAMETHASONE SODIUM PHOSPHATE (U.S.P.)	NA
38779-0071-08	J7638	DEXAMETHASONE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM	DEXAMETHASONE SODIUM PHOSPHATE (U.S.P.)	NA
38779-0071-08	J7638	DEXAMETHASONE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM	DEXAMETHASONE SODIUM PHOSPHATE (U.S.P.)	NA
38779-0082-04	J2001	INJECTION, LIDOCAINE HCL FOR INTRAVENOUS INFUSION, 10 MG	LIDOCAINE HCL (U.S.P.)	NA
38779-0082-05	J2001	INJECTION, LIDOCAINE HCL FOR INTRAVENOUS INFUSION, 10 MG	LIDOCAINE HCL (U.S.P.)	NA
38779-0082-08	J2001	INJECTION, LIDOCAINE HCL FOR INTRAVENOUS INFUSION, 10 MG	LIDOCAINE HCL (U.S.P.)	NA
38779-0082-09	J2001	INJECTION, LIDOCAINE HCL FOR INTRAVENOUS INFUSION, 10 MG	LIDOCAINE HCL (U.S.P.)	NA
38779-0101-08	J3350	INJECTION, UREA, UP TO 40 GM	UREA (U.S.P)	NA
16714-0727-01	J9263	INJECTION, OXALIPLATIN, 0.5 MG	OXALIPLATIN (1X10ML,SINGLE DOSE,PF) 5 MG/1 ML	IV
16714-0728-01	J9263	INJECTION, OXALIPLATIN, 0.5 MG	OXALIPLATIN (1X20ML,SINGLE DOSE,PF) 5 MG/1 ML	IV
16714-0742-01	Q2050	INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, NOT OTHERWISE SPECIFIED, 10 MG	DOXORUBICIN HCL LIPOSOME 2 MG/1 ML	IV
16714-0749-01	J0894	INJECTION, DECITABINE, 1 MG	DECITABINE (LYOPHILIZED) 50 MG	IV

HCPCS Code	Description	Billing Unit	SA Type
A7005	Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable	Each	N
A7006	Administration set, with small volume filter pneumatic nebulizer	Each	N
A7007	Large voume nebulizer, disposable, unfilled, used with aerosol compressor	Each	N
A7008	Large volume nebulizer, disposable, Prefilled, used with aerosol compressor	Each	N